Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 152
Selected: 0
NCT IDTitle
NCT03116984A Study of Comparison of TACE Combination With and Without EBRT for Advanced HCC
NCT05198154ctDNA Analysis to Monitor the Risk of Progression After First-line Immunotherapy in Patients With Advanced NSCLC
NCT06440954Efficacy and Resistance Mechanisms of IP in NSCLC With Leptomeningeal Metastases
NCT07654634Precision Antithrombotic Therapy
NCT05268172IFN-γ Combined With T Cells in the Treatment of Refractory Malignant Pleural Effusion and Ascites
NCT06350838Clinical Study to Investigate the Safety and Tolerance of Therapeutic BCG in Postoperative Adjuvant Therapy in Subjects With Moderate to High-risk Non-muscular Invasive Bladder Cancer (NMIBC)
NCT06836869Modified Tumor-free Techniques Operation to Cervical Cancer
NCT03286920Effect of Postoperative Family Nutrition Mode on Weight/BMI of Patients With Esophageal Cancer
NCT04030845Patient Report Outcome-Reconstruction and Oncoplastic Cohort
NCT04723875Postoperative Adjuvant Chemotherapy in Early-stage Cervical Cancer That Not Meet Criteria of Adjuvant Therapeutic According to NCCN Guideline
NCT07627620Camrelizumab Combined With Famitinib Malate and Chemotherapy for Treatment of Recurrent/ Metastatic Cervical Cancer
NCT02448979Esophagectomy in Middle and Lower Thoracic Esophageal Cancer Patients Through Left Versus Right Transthoracic Approach
NCT07005999Interventional Ablation for Early-stage Lung Cancer
NCT04826406A Study of Camrelizumab Combined Apatinib in Hepatocellular Carcinoma Previously Treated With Immune Checkpoint Inhibitors (ICIs).
NCT06328439A Study to Evaluate ANS014004 in Subjects With Locally Advanced or Metastatic Solid Tumors
NCT07083687Lorlatinib in ROS1+ NSCLC With Brain Metastasis
NCT03624309Anlotinib Plus Docetaxel for the Treatment of EGFR Wild-type Advanced Non-small-cell Lung Cancer
NCT07459296Becotatug Vedotin Plus Sintilimab in Locoregionally Advanced NPC
NCT05430906AK104 Combined With Chemotherapy as Neoadjuvant Treatment for Advanced Ovarian Cancer
NCT05326295Evaluation of Treatment Efficacy by Circulating Tumor Cell Phenotype Surveillance in Breast Cancer Patients
NCT02918747PEG-ASP+Gemoxd vs. PEG-ASP+CHOP as First-line Chemotherapy to Treatment NK/T-cell Lymphoma With Early Stage
NCT03637634The Children and Adolescents Nasopharyngeal Carcinoma Survivor Study
NCT07073755Real-World Study of Post-Resistance Treatment Strategies in Advanced Breast Cancer Following CDK4/6i, PIK3CA Inhibitors, or T-DXd
NCT06061146Tislelizumab Plus Concurrent Chemoradiation in Older With ESCC
NCT05206656Safety and Efficacy of Eribullin or Eribulin Combined With Anlotinib in Metastatic Breast Cancer
NCT07544056A Study of BEBT-209 Plus Chemotherapy in Patients With Locally Advanced or Metastatic Triple-Negative Breast Cancer
NCT07163481A Trial to Evaluate Sacituzumab Govitecan in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Metastatic Breast Cancer Progressed on CDK4/6 Inhibitors
NCT06748495Real-world First-line Serplulimab-based Immunochemotherapy for Extensive-stage Small Cell Lung Cancer
NCT06385990Utidelone (UTD1) Plus Capecitabine in Non-pCR TNBC After Neoadjuvant Therapy
NCT04459078Clinical Study of Camrelizumab Combined With APatinib and Albumin Paclitacxel in Patients With Advanced Lung Adenocarcinoma
NCT07237828Drain Removal on Postoperative Safety and Patient Satisfaction in R-E-NSM With Prepectoral DIBR
NCT05367739Real World Study on the Efficacy and Safety of Anti-HER2 Therapy
NCT01470495Combined Treatment of RFA and Sorafenib on Recurrent HCC
NCT06327698Cadonilimab in Combination With Anlotinib in the Treatment of Locally Progressive or Metastatic Melanoma With First-Line Therapy Failure
NCT07209787SIS-Reinforced vs. Conventional Anastomosis for Mid-to-Low Rectal Cancer: A Multicenter RCT on Anastomotic Leak
NCT03895788A Study of Niraparib in Combination With Brivanib in Recurrent Ovarian Cancer
NCT04922450Clinical Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy for Operable Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT05461690Phase II Study of Niraparib in Metastatic TNBC Patients With Homologous Recombination Deficiency
NCT06561308Clinical Efficacy Study of PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Advanced Endometrial Cancer
NCT04922567Efficacy and Safety of Lenalidomide Plus CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma
NCT05979961Phase III Trial of Concurrent Chemotherapy Alone in Patients With Low-risk Nasopharyngeal Carcinoma
NCT05535413UTD1 Combined With Capecitabine in Metastatic HER2-negative Breast Cancer Patients With Brain Metastases
NCT05427617Circulating Tumor DNA (ctDNA)-Guided Late-Line Treatment in Patients With Late-Stage Breast Cancer
NCT03351062Efficacy of Tamoxifen Versus Toremifene in CYP2D6 IM/PM of Premenopausal Patients With ER-positive Early Breast Cancer
NCT06022770Clinical Study on Nutrition Intervention in Patients With Esophageal and Gastric Cancer Treated With Chemotherapy
NCT02527057Diffusion-weighted Magnetic Resonance Imaging (DW-MRI )for Early Response Assessment in Patients With Esophageal Cancer
NCT06788002LDRT and Chemoimmunotherapy in NPC With Liver Metastasis
NCT06195228A Retrospective and Prospective Real-world Study of Molecular Typing in the Treatment of Advanced Thyroid Cancer
NCT05430399Utidelone Versus Docetaxel in HER2-negative Locally Advanced or Metastatic Breast Cancer
NCT01285219A Study Comparing Pegylated Filgrastim and Filgrastim in Support for Chemotherapy